Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990–2009)

Recent studies support an important role for human papillomavirus (HPV) in oropharyngeal squamous cell carcinomas (OPSCC), although the incidence varies widely depending on the geographic location and time period studied. The aim of this study was to determine the proportion of HPV in a large cohort of OPSCC in northern Spain in the years 1990–2009. Clinical records and paraffin embedded tumor specimens of 248 consecutive patients surgically treated for OPSCC (140 tonsillar and 108 base of tongue) between 1990 and 2009 were retrieved. OPSCC cases were histomorphologically evaluated, and protein expression of p16 and p53 was analyzed by immunohistochemistry. Detection of high‐risk HPV DNA was performed by GP5+/6+‐PCR and in situ hybridization (ISH). Thirty cases (12%) were positive for p16 immunostaining, of which eight (3.2% of the total series) were found positive for HPV type 16 by genotyping of GP5+6+‐PCR products. All HPV GP5+/6+‐PCR‐positive tumors were p53‐immunonegative, seven had a basaloid morphology and seven were also positive by HPV ISH. Presence of HPV correlated inversely with tobacco and alcohol consumption (p < 0.001), but not with age of onset of OPSCC. Overall survival was better in the HPV‐positive group, although not statistically significant (p = 0.175). OPSCC patients in northern Spain demonstrated a low involvement of HPV, increasing (although not significantly, p = 0.120) from 1.8% in 1990–1999 to 6.1% of cases in 2000–2009.

[1]  M. Rietbergen,et al.  Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm , 2013, International journal of cancer.

[2]  H. Quon,et al.  Controversies in treatment deintensification of human papillomavirus-associated oropharyngeal carcinomas: should we, how should we, and for whom? , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Wei Xu,et al.  Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  M. Curado,et al.  International incidence of oropharyngeal cancer: a population-based study. , 2012, Oral oncology.

[5]  M. Plummer,et al.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. , 2012, The Lancet. Oncology.

[6]  M. Curado,et al.  Trends in the incidence of oral cavity and oropharyngeal cancers in Spain , 2012, Head & neck.

[7]  M. Hermsen,et al.  Gene amplification and protein overexpression of EGFR and ERBB2 in sinonasal squamous cell carcinoma , 2012, Cancer.

[8]  A. El‐Naggar,et al.  p16 expression as a surrogate marker for HPV‐related oropharyngeal carcinoma: A guide for interpretative relevance and consistency , 2012, Head & neck.

[9]  G. Botti,et al.  Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization , 2012, Infectious Agents and Cancer.

[10]  M. Fresno,et al.  Wnt-pathway activation in intestinal-type sinonasal adenocarcinoma. , 2011, Rhinology.

[11]  R. Shaw,et al.  Evaluation of Human Papilloma Virus Diagnostic Testing in Oropharyngeal Squamous Cell Carcinoma: Sensitivity, Specificity, and Prognostic Discrimination , 2011, Clinical Cancer Research.

[12]  A. Psyrri,et al.  Oropharyngeal cancer: clinical implications of the HPV connection. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  J. Lissowska,et al.  Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. , 2011, International journal of epidemiology.

[14]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[15]  Gypsyamber D'Souza,et al.  HPV-associated head and neck cancer: a virus-related cancer epidemic. , 2010, The Lancet. Oncology.

[16]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[17]  P. Sparén,et al.  Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral‐induced carcinoma? , 2009, International journal of cancer.

[18]  A. Chaturvedi,et al.  Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  C. R. Leemans,et al.  A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen , 2007, International journal of cancer.

[20]  L. Mariani,et al.  High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  S. Franceschi,et al.  Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review , 2005, Cancer Epidemiology Biomarkers & Prevention.

[22]  S. Franceschi,et al.  Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. , 2003, Journal of the National Cancer Institute.

[23]  P. Rosenberg,et al.  J OURNAL OF C LINICAL O NCOLOGY Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States , 2014 .

[24]  F. Núñez Batalla,et al.  Using polymerase chain reaction to human papillomavirus in oral and pharyngolaryngeal carcinomas. , 1997, American journal of otolaryngology.

[25]  E. Somers International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.